Loading...
Unlocking tumor vascular barriers with CXCR3: Implications for cancer immunotherapy
Promising cancer immunotherapeutics depend on mobilization of cytotoxic T cells across tumor vascular barriers through mechanisms that are poorly understood. Recently, we discovered that the CXCR3 chemokine receptor uniquely functions as the master-regulator of cytotoxic CD8(+) T cell extravasation...
Saved in:
| Published in: | Oncoimmunology |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Taylor & Francis
2016
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4910745/ https://ncbi.nlm.nih.gov/pubmed/27467928 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2015.1116675 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|